# Clinical Pharmacology Study of CHF1535 pMDI 50/6 µg Versus The Free Combination In Asthmatic Children 5-11 Years Old

> **NCT01848769** · PHASE2 · COMPLETED · sponsor: **Chiesi Farmaceutici S.p.A.** · enrollment: 20 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** CHF1535 pMDI + AC Plus
- **DRUG:** BDP + AC Plus
- **DRUG:** Formoterol + AC Plus

## Key facts

- **NCT ID:** NCT01848769
- **Lead sponsor:** Chiesi Farmaceutici S.p.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2010-12
- **Final completion:** 2010-12
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2020-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01848769

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01848769, "Clinical Pharmacology Study of CHF1535 pMDI 50/6 µg Versus The Free Combination In Asthmatic Children 5-11 Years Old". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01848769. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*